S Molyneux
Overview
Explore the profile of S Molyneux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhatt R, Theobald S, Buzuzi S, Ros B, Vong S, Muraya K, et al.
Glob Health Epidemiol Genom
. 2018 Jun;
2:e8.
PMID: 29868219
Gender equity is imperative to the attainment of healthy lives and wellbeing of all, and promoting gender equity in leadership in the health sector is an important part of this...
2.
Molyneux S, Kar A, Wherrett B, Axon T, Bloor D
Opt Lett
. 2009 Oct;
18(24):2093.
PMID: 19829499
No abstract available.
3.
Nutt D, Glue P, Molyneux S, Clark E
Alcohol Clin Exp Res
. 1988 Feb;
12(1):14-8.
PMID: 2831749
Central alpha-2-adrenoceptor function was studied in seven withdrawing alcoholics and compared with seven normal controls using the clonidine challenge test. The alcoholic group had significantly elevated basal levels of blood...
4.
Nutt D, Molyneux S
Int Clin Psychopharmacol
. 1987 Apr;
2(2):151-7.
PMID: 3036941
The effects of a single (15 mg) dose of diazepam, a 3-week course of diazepam (25 mg/d) and its withdrawal on plasma MHPG and the reduction produced by clonidine (1.5...
5.
KOLAKOWSKA T, Gadhvi H, Molyneux S
Int Clin Psychopharmacol
. 1987 Jan;
2(1):83-8.
PMID: 2889761
The reports of hyperserotonaemia in chronic schizophrenics and the indications that fenfluramine, a serotonin-releasing drug, may be of therapeutic value in hyperserotonaemic autistic children, were the rationale for this clinical...